# Shandong New Time Pharmaceutical Co. Ltd., Linyi, China – FDA Inspections

Source: https://www.keypedia.com/companies/shandong-new-time-pharmaceutical-co-ltd/470fe860-121a-4594-b9a5-e6bf05ce1926

> Inspection records and compliance data for Shandong New Time Pharmaceutical Co. Ltd. in Linyi. 4 FDA inspections on record, 1 Form 483, last inspected July 09, 2024.

---

## Details

- Name: Shandong New Time Pharmaceutical Co. Ltd.
- FEI Number: 3006704412
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK
- Address Line 1: No. 1 North Outer Ring Road, Feixian
- City: Linyi
- Country Name: China
- Address: No. 1 North Outer Ring Road, Feixian, Linyi, China
- Country: China

## Related Documents

- [483 - Shandong New Time Pharmaceutical Co. Ltd. - 2024-07-09](https://www.keypedia.com/records/483/shandong-new-time-pharmaceutical-co-ltd/1ae1162b-59b7-4515-a05a-46d385e9b89f) — source: FDA, date: July 9, 2024
- FDA Inspection 1244268 - Shandong New Time Pharmaceutical Co. Ltd. - 2024-07-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 9, 2024
- [483 - Shandong New Time Pharmaceutical Co. Ltd. - 2024-07-01](https://www.keypedia.com/records/483/shandong-new-time-pharmaceutical-co-ltd/74710a97-7da7-4a05-9544-dfcc9791cb9e) — source: FDA, date: July 1, 2024
- [FDA Inspection 1054213 - Shandong New Time Pharmaceutical Co. Ltd. - 2018-05-11](https://www.keypedia.com/records/fda_inspections/shandong-new-time-pharmaceutical-co-ltd/52a2304e-d72c-4c91-9a20-7a87b78b52fc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 11, 2018
- FDA Inspection 967561 - Shandong New Time Pharmaceutical Co. Ltd. - 2016-03-25 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 25, 2016
- [FDA Inspection 854834 - Shandong New Time Pharmaceutical Co. Ltd. - 2013-08-23](https://www.keypedia.com/records/fda_inspections/shandong-new-time-pharmaceutical-co-ltd/74a7d8b7-8974-4a13-9725-72ecbb3bd48f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 23, 2013

## Related Companies

- [GlaxoSmithKline, LLC.](https://www.keypedia.com/companies/glaxosmithkline-llc/7ab59069-93ea-4898-a74a-874992c27286)
- [GlaxoSmithKline Manufacturing S.p.A.](https://www.keypedia.com/companies/glaxosmithkline-manufacturing-spa/11f7427f-c02e-4b80-91dd-f90cbe9b90a9)
- [Pharmaron (Ningbo) Technology Development Co., Ltd.](https://www.keypedia.com/companies/pharmaron-ningbo-technology-development-co-ltd/c40334bd-b474-48eb-91c6-51a228da2a42)
- [Exela Pharma Sciences LLC](https://www.keypedia.com/companies/exela-pharma-sciences-llc/4e6f3b32-adeb-41f4-b9dd-a8e7784569b3)
- [Baxter Healthcare Pty Ltd](https://www.keypedia.com/companies/baxter-healthcare-pty-ltd/a37e00b9-5cbd-4f45-922b-0f352f015507)
- [Lyocontract GmbH](https://www.keypedia.com/companies/lyocontract-gmbh/0c56698a-6a88-4c94-9de9-6e9f5172cf27)
- [Baxter SA](https://www.keypedia.com/companies/baxter-sa/4cc540bc-58e1-460a-be6e-c6c8c7d2ee47)
- [Cipla, Ltd.](https://www.keypedia.com/companies/cipla-ltd/f726d9c8-4fe7-456e-848c-f9ef86f00e4f)
- [BioMarin International Limited](https://www.keypedia.com/companies/biomarin-international-limited/dbd5911b-3dec-4a03-a980-1e45a5f973a4)
- [Baxter Pharmaceuticals India Pvt Ltd](https://www.keypedia.com/companies/baxter-pharmaceuticals-india-pvt-ltd/dc51d849-2ff2-4ad0-bb54-cb013fd2e24d)

## Related Officers

- [Investigator](https://www.keypedia.com/people/michael-a-charles/f83241f0-ae3b-4535-ac03-e790bbf666ca)